Keybank National Association Apellis Pharmaceuticals, Inc. Transaction History
Keybank National Association
- $23.9 Billion
- Q1 2024
A detailed history of Keybank National Association transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Keybank National Association holds 6,570 shares of APLS stock, worth $262,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,570
Previous 6,549
0.32%
Holding current value
$262,800
Previous $392,000
1.53%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
336Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$602 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$454 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$444 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$380 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$220 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.39B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...